Back
CytomX Therapeutics Stock Price Chart
Sponsored
CTMX
Sponsored
The little-known AI stock you need to read about now...
Get the name - FREE.
Buy
64
CTMX
CytomX Therapeutics
Last Price:
5.10
Seasonality Move:
-13.94%
7 Day Trial
ALL ACCESS PASS
$
7
My #1 Coin is...
All the details are on the next page.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CTMX is experiencing buying pressure, which is a positive indicator for future bullish movement.
CytomX Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.07 | Buy |
20-day SMA: | 2.01 | Buy |
50-day SMA: | 2.12 | Buy |
200-day SMA: | 1.61 | Buy |
8-day EMA: | 2.43 | Buy |
20-day EMA: | 2.12 | Buy |
50-day EMA: | 2.02 | Buy |
200-day EMA: | 1.77 | Buy |
CytomX Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.15 | Buy |
Relative Strength Index (14 RSI): | 89.88 | Buy |
Chaikin Money Flow: | 107919037 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.37 - 2.71) | Buy |
Bollinger Bands (100): | (1.33 - 2.31) | Buy |
CytomX Therapeutics Technical Analysis
Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for CytomX Therapeutics Stock
Is CytomX Therapeutics Stock a Buy?
- CytomX Therapeutics share price is 5.13 while CTMX 8-day simple moving average is 2.07, which is a Buy signal.
- The stock price of CTMX is 5.13 while CytomX Therapeutics 20-day SMA is 2.01, which makes it a Buy.
- CytomX Therapeutics 50-day simple moving average is 2.12 while CTMX share price is 5.13, making it a Buy technically.
- CTMX stock price is 5.13 and CytomX Therapeutics 200-day simple moving average is 1.61, creating a Buy signal.
CTMX Technical Analysis vs Fundamental Analysis
Buy
64
CytomX Therapeutics (CTMX)
is a Buy
Is CytomX Therapeutics a Buy or a Sell?
-
CytomX Therapeutics stock is rated a Buy
The current CytomX Therapeutics [CTMX] share price is $5.13. The Score for CTMX is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
CytomX Therapeutics Stock Info
Market Cap:
347.41M
Price in USD:
5.13
Share Volume:
203.26M
CytomX Therapeutics 52-Week Range
52-Week High:
5.85
52-Week Low:
1.04
Buy
64
CytomX Therapeutics (CTMX)
is a Buy
CytomX Therapeutics Share Price Forecast
-
What is the CytomX Therapeutics stock price today?
The CytomX Therapeutics stock price is 5.13 USD today. -
Will CTMX stock go up or go down?
CytomX Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is CytomX Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, CytomX Therapeutics is not overvalued.
Is CytomX Therapeutics Stock a Buy?
- CytomX Therapeutics share price is 5.13 while CTMX 8-day exponential moving average is 2.43, which is a Buy signal.
- The stock price of CTMX is 5.13 while CytomX Therapeutics 20-day EMA is 2.12, which makes it a Buy.
- CytomX Therapeutics 50-day exponential moving average is 2.02 while CTMX share price is 5.13, making it a Buy technically.
- CTMX stock price is 5.13 and CytomX Therapeutics 200-day simple moving average is 1.77, creating a Buy signal.
Fundamental Analysis of CytomX Therapeutics
Is CytomX Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.24 per share, and a decrease next year of $0.19 per share.
Technical Analysis of CytomX Therapeutics
Should I short CytomX Therapeutics stock?
- CTMX Moving Average Covergence Divergence (MACD) indicator is 0.15, suggesting CytomX Therapeutics is a Buy
- CytomX Therapeutics Relative Strength Index (RSI) is 89.88, which suggest CytomX Therapeutics is overbought
- The Bollinger Bands (25) for CytomX Therapeutics is (1.37 - 2.71), which suggest CytomX Therapeutics is a Buy
- The Bollinger Bands (100) for CytomX Therapeutics is (1.33 - 2.31), which suggest CytomX Therapeutics is a Buy
* CytomX Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.